Outcomes of Central Nervous System Infections Treated by an Outpatient Parenteral Antimicrobial Therapy Program in a Public Teaching Hospital
- 30 September 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 29 (2) , e82-e87
Abstract
Background: Outpatient parenteral antimicrobial therapy (OPAT) has been safely used to treat a variety of infections. However, limited data are available on the safety and efficacy of OPAT for central nervous system (CNS) infections. Methods: This was a retrospective, single-center study evaluating the safety and efficacy of OPAT in patients with CNS infections between July 1, 2009, and May 31, 2016. Demographic, medical, infection-specific, and drug-specific data were collected for each patient. Patients were categorized as clinical cure, probable cure, or treatment failure based on resolution or recurrence of infection for up to 1 year after OPAT completion. Safety of OPAT was evaluated through adverse drug event (ADE) and line complication (LC) monitoring. Readmission rates from OPAT-related ADE and LC were also recorded. Results: Forty-seven patients with CNS infections (mean age, 45.3 years; 70.2% male) received OPAT for a median duration of 12 days (range, 2–144 days); 1 patient was excluded from efficacy analysis because of hospice transition. Thirty-seven patients (80.4%) achieved clinical cure, 7 patients (15.2%) had probable cure, and 2 patients (4.3%) experienced treatment failure. Three patients (6.4%) experienced ADE and 4 patients (8.5%) experienced LC during OPAT. Five patients (10.6%) required rehospitalization because of worsening infection (n = 1), LC (n = 2), cerebrospinal fluid leak repair (n = 1), and insurance issues (n = 1). Six patients (12.8%) required a therapy change because of ADE or LC. Conclusions: Treating CNS infections with OPAT seems to be safe and effective based on the low failure and complication rates observed in this study.Keywords
This publication has 24 references indexed in Scilit:
- Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programmeJournal of Antimicrobial Chemotherapy, 2013
- Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspectiveJournal of Antimicrobial Chemotherapy, 2009
- Experience of Infectious Diseases Consultants with Outpatient Parenteral Antimicrobial Therapy: Results of an Emerging Infections Network SurveyClinical Infectious Diseases, 2006
- Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospitalBMJ, 2004
- Practice Guidelines for the Management of Bacterial MeningitisClinical Infectious Diseases, 2004
- Practice Guidelines for Outpatient Parenteral Antimicrobial TherapyClinical Infectious Diseases, 2004
- Outpatient Parenteral Antimicrobial Therapy for Central Nervous System InfectionsClinical Infectious Diseases, 1999
- Practice Guidelines for Community‐Based Parenteral Anti‐Infective TherapyClinical Infectious Diseases, 1997
- Outpatient therapy of serious pediatric infections with ceftriaxoneThe Pediatric Infectious Disease Journal, 1988
- Outpatient treatment of serious infections in infants and children with ceftriaxoneThe Journal of Pediatrics, 1987